OptimizeRx

OptimizeRx Receivables

The Accounts Receivable of OptimizeRx (OPRX) as of Oct 9, 2026 is 38.21 M USD. In the previous year, Accounts Receivable was 36.25 M USD — a change of 5.40% (higher).

Receivables

38.21 MUSD

YoY

5.40%

Last updated:

Accounts Receivable of OptimizeRx is 2024 38.21 M USD. Accounts Receivable of OptimizeRx was 2023 36.25 M USD. It decreases by 5.40% higher compared to the previous year.

The OptimizeRx Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2017
3.40 M USD
Jan 1, 2018
6.50 M USD
Jan 1, 2019
7.40 M USD
Jan 1, 2020
17.90 M USD
Jan 1, 2021
24.80 M USD
Jan 1, 2022
22.20 M USD
Jan 1, 2023
36.25 M USD
Jan 1, 2024
38.21 M USD
The OptimizeRx Receivables history
YEARReceivablesYoY
38.21 MUSD+5.40%
36.25 MUSD+63.30%
22.20 MUSD-10.48%
24.80 MUSD+38.55%
17.90 MUSD+141.89%
7.40 MUSD+13.85%
6.50 MUSD+91.18%
3.40 MUSD+9.68%
3.10 MUSD+10.71%
2.80 MUSD+33.33%
2.10 MUSD—
Access this data via the Eulerpool API
Get Free API Key

OptimizeRx Stock analysis

What does OptimizeRx do? The OPTIMIZERx Corporation is an emerging US company that is pursuing a revolutionary approach to solving challenges in healthcare. The company was founded in 2006 and is headquartered in Rochester, Michigan. OPTIMIZERx initially started as a provider of discount incentives to improve medication management. They later developed an innovative E-Prescribing platform to ensure the quick and secure delivery of medications to patients. Their business model focuses on providing scalable platforms and services to simplify and improve patient data management and communication. OPTIMIZERx offers products such as eCoupon, SampleMD, OptimizeRx Digital Therapeutic Support, and OptimizeRx 360. These platforms and services are sold to pharmaceutical companies, doctors, patients, and pharmacies to help reduce costs and optimize business processes. The company is divided into different categories including E-Prescribing, Patient-Centered Support, Point-of-Care Services, and Channel and Content Management. Overall, OPTIMIZERx aims to improve healthcare services through innovative technology and has achieved significant milestones such as a strong customer base and sustainable financial foundation. OptimizeRx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OptimizeRx stock

Accounts Receivable of OptimizeRx is 38.21 M USD in 2024.

Accounts Receivable of OptimizeRx changed from 36.25 M USD to 38.21 M USD, representing a 5.40% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable OptimizeRx since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's OptimizeRx historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — OptimizeRx

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — OptimizeRx